心肌保护
人参
微泡
医学
免疫系统
TLR4型
药理学
外体
炎症
促炎细胞因子
体内
再灌注损伤
免疫学
串扰
信号转导
体外
细胞因子
脂多糖
MAPK/ERK通路
免疫
细胞生物学
心肌炎
PI3K/AKT/mTOR通路
肠粘膜
作者
Y. Li,Lin Sun,Yan Wang,Hua-Yi YANG,De-Sheng Xu,Yan-Zhu ZHONG,Zhang Juan-hong,Yang Li,Fang-Cao Pi,Qi Li,Z L Li,Wei‐Ting Wang,Chen M,Meng-Nan Liu,Qidi Sun,Ming-Ming Peng,Elaine Lai‐Han Leung,Qi-Biao Wu,Ya-Ling Han,Liang Liu
标识
DOI:10.1016/j.phrs.2026.108217
摘要
Myocardial ischemia-reperfusion injury (MIRI) remains a critical clinical condition with limited preventive and therapeutic strategies, underscoring the need for novel interventions. The gut-heart axis and exosomal crosstalk hold therapeutic promise for cardioprotection, yet the fundamental question of which specific gut cells release the beneficial exosomes is unanswered. This study aimed to elucidate whether ginseng polysaccharides WGPA exert remote cardiac protection by regulating intestinal immune homeostasis, specifically through promoting the release of exosomes from regulatory T cells (Tregs). Using integrated in vivo and in vitro models, we evaluated the protective effects of WGPA against MIRI. The results demonstrated that WGPA pretreatment significantly attenuated myocardial injury and improved cardiac function. Mechanistically, WGPA selectively activated intestinal Tregs and enhanced the release of HSP70-enriched exosomes. These exosomes entered systemic circulation and were delivered to the heart, where surface HSP70 interacted with TLR4 on cardiomyocytes, activating downstream protective signaling pathways and ultimately suppressing cardiomyocyte death and inflammatory responses. Our study reveals for the first time a complete mechanism by which medicinal plant polysaccharides confer cross-organ cardioprotection via the "intestinal Tregs-exosome-heart" axis, providing a novel theoretical basis and a potential intervention strategy for the prevention and treatment of MIRI.
科研通智能强力驱动
Strongly Powered by AbleSci AI